Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Genomadix logo — Lab Quality Results Without The Lab! Revolutionizing diagnos...

Genomadix

Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results.

Founded 2021 Canada Kanata, Canada 30 employees Corporate Round Biotechnology

General Information

Company Name Genomadix
Founded Year 2021
Location Canada Kanata, Canada
Employees 30
Industries Biotechnology
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with Genomadix. To contact Genomadix, visit genomadix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genomadix compare?

A PDF of Genomadix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genomadix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genomadix

Genomadix, headquartered in Ottawa, Canada, is advancing the field of Biotechnology with its innovative approach to diagnostics. Founded in 2021, the company is making waves with its real-time qPCR point of need technology that promises "Lab Quality Results Without The Lab!"

The company is renowned for its Genomadix Cube, a molecular diagnostic instrument engineered for portability, precision, and rapid results, delivering outcomes in about an hour. The Cube is versatile, supporting tests like rapid CYP2C19 Genotyping, environmental testing for Legionella pneumophila, and Apolipoprotein E (ApoE) genotyping. It also offers an open platform, CubeX, for various qPCR applications, extending its utility in research environments.

With over 3 million hours dedicated to R&D, 11 patents, and 30 scientific publications, Genomadix has secured its position as a leader in this niche. A significant corporate round investment on 29 August 2022 by the prestigious Mayo Clinic underscores the company's growth potential and innovative edge.

Business keywords: DNA diagnostics, Point of care testing, Real-time qPCR, Molecular diagnostics, Precision medicine, Genotyping, Environmental testing, Medical devices, Personalized medicine, Pharmacogenetics, Infectious diseases, Water safety testing, Research and development, Portable diagnostics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round Undisclosed 1
Mayo Clinic
Mayo Clinic
29 Aug 2022

Genomadix Alternatives & Competitors

View All Alternatives
Genomadix vs
Lucira Health
Lucira Health

Empowering you with rapid, lab-accurate molecular testing in the palm of your hand

Post-IPO Debt
51-200 employees
Biotechnology, Health Care
Genomadix vs
LSK Technologies Inc. (Now part of Nicoya)
LSK Technologies Inc. (Now part of Nicoya) Canada

Lab-Quality Testing Without the Lab: Affordable Solutions for Fast and Accurate Results

Seed
2 employees
Biotechnology, Digital Health
Genomadix vs
Molbio Diagnostics
Molbio Diagnostics India

Molbio is a disruptor in the global healthcare landscape, shifting existing paradigms in point-of-ca...

Venture round
588 employees
Biotechnology, Health Care
View all alternatives

FAQ About Genomadix

Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results.
Genomadix was founded in 2021.
Genomadix is headquartered in Kanata, Canada.
Genomadix operates in Biotechnology. Its work centres on DNA diagnostics, Point of care testing, Real-time qPCR and Molecular diagnostics.
Genomadix has approximately 30 employees.
Genomadix has completed 1 funding round. The latest funding stage is Corporate Round.
Top alternatives and competitors to Genomadix include Lucira Health, LSK Technologies Inc. (Now part of Nicoya), Molbio Diagnostics, STAT-Dx, EMPE Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genomadix and Lucira Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genomadix, https://bouncewatch.com/company/genomadix, updated 27 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout